Plain-English translation of NCT04664634 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a wearable sensor patch called the Aria sensor that sticks to your skin and continuously monitors your swallowing. The patch provides gentle vibration signals (called haptic cues) to help remind you to swallow more often, which may help reduce excessive drooling — a common problem for people with Parkinson's disease.
Swallowing difficulties and drooling affect many people with Parkinson's disease and can be uncomfortable and embarrassing. This trial aims to develop a simple, wearable device that could help manage these symptoms without surgery or medication adjustments.
You likely qualify if…
You likely don't qualify if…
You would wear the Aria sensor patch for 3 weeks total. During the first week, the patch will simply monitor your swallowing without any vibration cues. In the second week, the patch will begin sending gentle vibration reminders to encourage you to swallow more frequently. In the third week, it returns to monitoring only. You'll need to visit the research clinic for assessments and have your swallowing evaluated.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Phase
Large-scale testing
Sponsor
Northwestern University
Enrollment target
~60 participants
Started
April 2025
Primary completion
October 2026
Age range
22 Years and older
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ankita Bhutada
Northwestern University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.